N Nitescu
Overview
Explore the profile of N Nitescu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nitescu N, Bengtsson A, Bengtson J
Perfusion
. 2002 Sep;
17(5):357-62.
PMID: 12243440
Background: Red blood cells may be destroyed by autotransfusion processing during intraoperative salvage. The aim of the present study was to evaluate the blood component recovery rate of techniques built...
2.
Nilsson A, Nitescu N, Chen Y, Guron G, Marcussen N, Matejka G, et al.
Am J Physiol Regul Integr Comp Physiol
. 2000 Aug;
279(3):R1050-60.
PMID: 10956265
An intact renin-angiotensin system (RAS) during nephrogenesis is essential for normal renal development. We have shown previously that neonatal inhibition of the RAS, either with ANG II type 1-receptor blockade...
3.
Mechanisms of impaired urinary concentrating ability in adult rats treated neonatally with enalapril
Guron G, Nilsson A, Nitescu N, Nielsen S, Sundelin B, Frokiaer J, et al.
Acta Physiol Scand
. 1999 Mar;
165(1):103-12.
PMID: 10072103
Neonatal angiotensin-converting enzyme inhibition or angiotensin II type-1 receptor blockade induces irreversible renal histological abnormalities and an impaired urinary concentrating ability in the rat. The aim of the present study...
4.
Renal adaptation to dietary sodium restriction and loading in rats treated neonatally with enalapril
Guron G, Nilsson A, Dibona G, Sundelin B, Nitescu N, Friberg P
Am J Physiol
. 1997 Nov;
273(4):R1421-9.
PMID: 9362308
Neonatal treatment of rats with angiotensin-converting enzyme inhibitors or the angiotensin II type 1 receptor antagonist losartan induces irreversible renal histological abnormalities, mainly papillary atrophy, in association with an impairment...